| The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nature microbiology 5 (4), 536-544, 2020 | 6262 | 2020 |
| Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus Y Wan, J Shang, R Graham, RS Baric, F Li Journal of virology 94 (7), 10.1128/jvi. 00127-20, 2020 | 5689 | 2020 |
| Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking M Wang, JJ Carver, VV Phelan, LM Sanchez, N Garg, Y Peng, ... Nature biotechnology 34 (8), 828-837, 2016 | 3805 | 2016 |
| Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses AMQ King, E Lefkowitz, MJ Adams, EB Carstens Elsevier, 2011 | 3026 | 2011 |
| Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group AE Gorbalenya, SC Baker, RS Baric, RJ de Groot, C Drosten, ... BioRxiv, 2020 | 2596 | 2020 |
| Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won, AJ Brown, ... Nature communications 11 (1), 222, 2020 | 2132 | 2020 |
| Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell 183 (4), 996-1012. e19, 2020 | 1958 | 2020 |
| Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses TP Sheahan, AC Sims, RL Graham, VD Menachery, LE Gralinski, ... Science translational medicine 9 (396), eaal3653, 2017 | 1927 | 2017 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1724 | 2020 |
| Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group RJ De Groot, SC Baker, RS Baric, CS Brown, C Drosten, L Enjuanes, ... Journal of virology 87 (14), 7790-7792, 2013 | 1692 | 2013 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1636 | 2020 |
| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1618 | 2020 |
| Norwalk virus: how infectious is it? PFM Teunis, CL Moe, P Liu, S E. Miller, L Lindesmith, RS Baric, ... Journal of medical virology 80 (8), 1468-1476, 2008 | 1473 | 2008 |
| Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease ML Agostini, EL Andres, AC Sims, RL Graham, TP Sheahan, X Lu, ... MBio 9 (2), 10.1128/mbio. 00221-18, 2018 | 1447 | 2018 |
| Human susceptibility and resistance to Norwalk virus infection L Lindesmith, C Moe, S Marionneau, N Ruvoen, XI Jiang, L Lindblad, ... Nature medicine 9 (5), 548-553, 2003 | 1379 | 2003 |
| A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence VD Menachery, BL Yount, K Debbink, S Agnihothram, LE Gralinski, ... Nature medicine 21 (12), 1508-1513, 2015 | 1251 | 2015 |
| Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, B Flynn, KE Foulds, JR Francica, S Boyoglu-Barnum, ... New England Journal of Medicine 383 (16), 1544-1555, 2020 | 1215 | 2020 |
| Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture AJW Te Velthuis, SHE van den Worm, AC Sims, RS Baric, EJ Snijder, ... PLoS pathogens 6 (11), e1001176, 2010 | 1177 | 2010 |
| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1167 | 2020 |
| An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice TP Sheahan, AC Sims, S Zhou, RL Graham, AJ Pruijssers, ML Agostini, ... Science translational medicine 12 (541), eabb5883, 2020 | 1151 | 2020 |
